KEGG   ORTHOLOGY: K04857Help
Entry
K04857                      KO                                     

Name
CACNA1S, CAV1.1
Definition
voltage-dependent calcium channel L type alpha-1S
Pathway
ko04010  MAPK signaling pathway
ko04020  Calcium signaling pathway
ko04022  cGMP-PKG signaling pathway
ko04024  cAMP signaling pathway
ko04260  Cardiac muscle contraction
ko04261  Adrenergic signaling in cardiomyocytes
ko04270  Vascular smooth muscle contraction
ko04723  Retrograde endocannabinoid signaling
ko04725  Cholinergic synapse
ko04726  Serotonergic synapse
ko04727  GABAergic synapse
ko04911  Insulin secretion
ko04912  GnRH signaling pathway
ko04921  Oxytocin signaling pathway
ko04924  Renin secretion
ko04925  Aldosterone synthesis and secretion
ko04927  Cortisol synthesis and secretion
ko04929  GnRH secretion
ko04934  Cushing syndrome
ko04935  Growth hormone synthesis, secretion and action
ko05010  Alzheimer disease
ko05410  Hypertrophic cardiomyopathy (HCM)
ko05412  Arrhythmogenic right ventricular cardiomyopathy (ARVC)
ko05414  Dilated cardiomyopathy (DCM)
Disease
H00215  Periodic paralysis
H00746  Hypokalemic periodic paralysis (HypoPP)
Brite
KEGG Orthology (KO) [BR:ko00001]
 09130 Environmental Information Processing
  09132 Signal transduction
   04010 MAPK signaling pathway
    K04857  CACNA1S, CAV1.1; voltage-dependent calcium channel L type alpha-1S
   04020 Calcium signaling pathway
    K04857  CACNA1S, CAV1.1; voltage-dependent calcium channel L type alpha-1S
   04024 cAMP signaling pathway
    K04857  CACNA1S, CAV1.1; voltage-dependent calcium channel L type alpha-1S
   04022 cGMP-PKG signaling pathway
    K04857  CACNA1S, CAV1.1; voltage-dependent calcium channel L type alpha-1S
 09150 Organismal Systems
  09152 Endocrine system
   04911 Insulin secretion
    K04857  CACNA1S, CAV1.1; voltage-dependent calcium channel L type alpha-1S
   04929 GnRH secretion
    K04857  CACNA1S, CAV1.1; voltage-dependent calcium channel L type alpha-1S
   04912 GnRH signaling pathway
    K04857  CACNA1S, CAV1.1; voltage-dependent calcium channel L type alpha-1S
   04921 Oxytocin signaling pathway
    K04857  CACNA1S, CAV1.1; voltage-dependent calcium channel L type alpha-1S
   04935 Growth hormone synthesis, secretion and action
    K04857  CACNA1S, CAV1.1; voltage-dependent calcium channel L type alpha-1S
   04924 Renin secretion
    K04857  CACNA1S, CAV1.1; voltage-dependent calcium channel L type alpha-1S
   04925 Aldosterone synthesis and secretion
    K04857  CACNA1S, CAV1.1; voltage-dependent calcium channel L type alpha-1S
   04927 Cortisol synthesis and secretion
    K04857  CACNA1S, CAV1.1; voltage-dependent calcium channel L type alpha-1S
  09153 Circulatory system
   04260 Cardiac muscle contraction
    K04857  CACNA1S, CAV1.1; voltage-dependent calcium channel L type alpha-1S
   04261 Adrenergic signaling in cardiomyocytes
    K04857  CACNA1S, CAV1.1; voltage-dependent calcium channel L type alpha-1S
   04270 Vascular smooth muscle contraction
    K04857  CACNA1S, CAV1.1; voltage-dependent calcium channel L type alpha-1S
  09156 Nervous system
   04727 GABAergic synapse
    K04857  CACNA1S, CAV1.1; voltage-dependent calcium channel L type alpha-1S
   04725 Cholinergic synapse
    K04857  CACNA1S, CAV1.1; voltage-dependent calcium channel L type alpha-1S
   04726 Serotonergic synapse
    K04857  CACNA1S, CAV1.1; voltage-dependent calcium channel L type alpha-1S
   04723 Retrograde endocannabinoid signaling
    K04857  CACNA1S, CAV1.1; voltage-dependent calcium channel L type alpha-1S
 09160 Human Diseases
  09164 Neurodegenerative disease
   05010 Alzheimer disease
    K04857  CACNA1S, CAV1.1; voltage-dependent calcium channel L type alpha-1S
  09166 Cardiovascular disease
   05410 Hypertrophic cardiomyopathy (HCM)
    K04857  CACNA1S, CAV1.1; voltage-dependent calcium channel L type alpha-1S
   05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)
    K04857  CACNA1S, CAV1.1; voltage-dependent calcium channel L type alpha-1S
   05414 Dilated cardiomyopathy (DCM)
    K04857  CACNA1S, CAV1.1; voltage-dependent calcium channel L type alpha-1S
  09167 Endocrine and metabolic disease
   04934 Cushing syndrome
    K04857  CACNA1S, CAV1.1; voltage-dependent calcium channel L type alpha-1S
 09180 Brite Hierarchies
  09183 Protein families: signaling and cellular processes
   04040 Ion channels
    K04857  CACNA1S, CAV1.1; voltage-dependent calcium channel L type alpha-1S
Ion channels [BR:ko04040]
 Voltage-gated cation channels
  Calcium channel, voltage-gated (Cav)
   K04857  CACNA1S, CAV1.1; voltage-dependent calcium channel L type alpha-1S
BRITE hierarchy
Other DBs
GO: 0005245
TC: 1.A.1.11.2
Genes
HSA: 779(CACNA1S)
PTR: 469635(CACNA1S)
PPS: 100982136(CACNA1S)
GGO: 101150507(CACNA1S)
PON: 100433948(CACNA1S)
NLE: 100589614(CACNA1S)
MCC: 708706(CACNA1S)
MCF: 102131553(CACNA1S)
CSAB: 103230339(CACNA1S)
RRO: 104661868(CACNA1S)
RBB: 108545075(CACNA1S)
CJC: 100390112(CACNA1S)
SBQ: 101042219(CACNA1S)
MMU: 12292(Cacna1s)
MCAL: 110296075(Cacna1s)
MPAH: 110322010(Cacna1s)
RNO: 682930(Cacna1s)
MUN: 110548425(Cacna1s)
CGE: 100765508(Cacna1s)
NGI: 103731814(Cacna1s)
HGL: 101726232(Cacna1s)
OCU: 100009585(CACNA1S)
TUP: 102481015(CACNA1S)
CFA: 490244(CACNA1S)
VVP: 112934538(CACNA1S)
AML: 100472835(CACNA1S)
UMR: 103657769(CACNA1S)
UAH: 113242563(CACNA1S)
ORO: 101385947(CACNA1S)
FCA: 654399(CACNA1S)
PTG: 102949808(CACNA1S)
PPAD: 109256096(CACNA1S)
AJU: 106974264(CACNA1S)
BTA: 100337204(CACNA1S)
BOM: 102272241(CACNA1S)
BBUB: 102397191(CACNA1S)
CHX: 102176151(CACNA1S) 108634554
OAS: 101108767(CACNA1S)
SSC: 100622149(CACNA1S)
CFR: 102507309
CDK: 105090835(CACNA1S)
BACU: 103014409(CACNA1S)
LVE: 103090575(CACNA1S)
OOR: 101275416(CACNA1S)
DLE: 111168340(CACNA1S)
PCAD: 102987099(CACNA1S)
ECB: 100034092(CACNA1S)
EPZ: 103565109(CACNA1S)
EAI: 106823553(CACNA1S)
MYB: 102243265(CACNA1S)
MYD: 102760374(CACNA1S)
MNA: 107536018(CACNA1S)
HAI: 109380439(CACNA1S)
DRO: 112318756(CACNA1S)
PALE: 102896136(CACNA1S)
RAY: 107513628(CACNA1S)
MJV: 108396001(CACNA1S)
LAV: 100673089(CACNA1S)
TMU: 101343945
MDO: 100013684(CACNA1S)
SHR: 100917433(CACNA1S)
PCW: 110219570(CACNA1S)
OAA: 100093447(CACNA1S)
GGA: 395985(CATSPER2)
MGP: 100547445(CACNA1S)
CJO: 107324611(CACNA1S)
NMEL: 110388201(CACNA1S)
APLA: 101801311(CACNA1S)
ACYG: 106046137(CACNA1S)
TGU: 100220193(CACNA1S)
LSR: 110469152(CACNA1S)
SCAN: 103822432(CACNA1S)
GFR: 102037957(CACNA1S)
FAB: 101821759(CACNA1S)
PHI: 102111358(CACNA1S)
PMAJ: 107214754(CACNA1S)
CCAE: 111939717(CACNA1S)
CCW: 104692446(CACNA1S)
ETL: 114064775(CACNA1S)
FPG: 101914764(CACNA1S)
FCH: 102058184(CACNA1S)
CLV: 102092229(CACNA1S)
EGZ: 104122032(CACNA1S)
NNI: 104011070(CACNA1S)
ACUN: 113488965(CACNA1S)
PADL: 103913818(CACNA1S)
AAM: 106500235(CACNA1S)
ASN: 102377229(CACNA1S)
AMJ: 102563699(CACNA1S)
PSS: 102453880
CPIC: 101932307(CACNA1S) 101934976
ACS: 100551605(cacna1s)
PVT: 110085291(CACNA1S)
PBI: 103055781(CACNA1S)
PMUR: 107289042(CACNA1S)
TSR: 106549619(CACNA1S)
PMUA: 114599194(CACNA1S)
GJA: 107110972(CACNA1S)
XLA: 100381134(cacna1s.S) 108707491
XTR: 100485035(cacna1s)
NPR: 108804869(CACNA1S)
DRE: 405791(cacna1sb) 570683(cacna1sa)
PHYP: 113525738 113526802(cacna1s)
EEE: 113581084 113586976(cacna1s)
TRU: 101065120
NCC: 104956859(cacna1s)
MZE: 101479917(cacna1s)
ONL: 100704349(cacna1s)
OLA: 101170269
XMA: 102237099(cacna1s)
XCO: 114148648(cacna1s)
PRET: 103467335(cacna1s)
CVG: 107086768(cacna1s)
NFU: 107390862(cacna1s)
KMR: 108244587(cacna1s)
ALIM: 106525038(cacna1s)
AOCE: 111564440(cacna1s) 111581021 111586752
POV: 109630550(cacna1s)
BPEC: 110164965(cacna1s)
MALB: 109968827(cacna1s)
OTW: 112255319
SFM: 108931184 108933625(cacna1s)
LCM: 102356715(CACNA1S)
CMK: 103190861
 » show all
TaxonomyKoalaUniProt
Reference
  Authors
Pirone A, Schredelseker J, Tuluc P, Gravino E, Fortunato G, Flucher BE, Carsana A, Salvatore F, Grabner M
  Title
Identification and functional characterization of malignant hyperthermia mutation T1354S in the outer pore of the Cavalpha1S-subunit.
  Journal
Am J Physiol Cell Physiol 299:C1345-54 (2010)
DOI:10.1152/ajpcell.00008.2010
  Sequence
[hsa:779]
Reference
PMID:8004673
  Authors
Ptacek LJ, Tawil R, Griggs RC, Engel AG, Layzer RB, Kwiecinski H, McManis PG, Santiago L, Moore M, Fouad G, et al.
  Title
Dihydropyridine receptor mutations cause hypokalemic periodic paralysis.
  Journal
Cell 77:863-8 (1994)
DOI:10.1016/0092-8674(94)90135-X
  Sequence
[hsa:779]
LinkDB All DBs

DBGET integrated database retrieval system